Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
Income Statement
Earnings Waterfall
Cumberland Pharmaceuticals Inc
Revenue
|
39.6m
USD
|
Cost of Revenue
|
-6.1m
USD
|
Gross Profit
|
33.5m
USD
|
Operating Expenses
|
-39.7m
USD
|
Operating Income
|
-6.2m
USD
|
Other Expenses
|
-68.5k
USD
|
Net Income
|
-6.3m
USD
|
Income Statement
Cumberland Pharmaceuticals Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
32
N/A
|
30
-7%
|
33
+9%
|
36
+10%
|
37
+3%
|
38
+2%
|
37
-2%
|
35
-5%
|
34
-4%
|
33
-3%
|
31
-5%
|
32
+3%
|
33
+3%
|
35
+6%
|
36
+4%
|
39
+7%
|
41
+7%
|
40
-3%
|
42
+4%
|
39
-7%
|
29
-25%
|
29
+0%
|
29
-3%
|
27
-5%
|
34
+26%
|
34
-1%
|
34
+1%
|
36
+7%
|
37
+3%
|
40
+6%
|
39
-1%
|
38
-3%
|
36
-5%
|
37
+2%
|
38
+3%
|
41
+9%
|
42
+2%
|
40
-5%
|
41
+1%
|
39
-3%
|
40
+1%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(5)
|
(5)
|
(6)
|
(6)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(7)
|
(7)
|
(7)
|
(8)
|
(7)
|
(7)
|
(6)
|
(6)
|
(6)
|
(7)
|
(7)
|
(7)
|
(8)
|
(9)
|
(8)
|
(9)
|
(8)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(9)
|
(9)
|
(9)
|
(9)
|
(6)
|
|
Gross Profit |
27
N/A
|
24
-8%
|
27
+10%
|
30
+11%
|
32
+7%
|
32
+2%
|
32
-2%
|
30
-5%
|
29
-5%
|
28
-4%
|
26
-5%
|
26
0%
|
27
+4%
|
29
+6%
|
30
+3%
|
32
+7%
|
34
+6%
|
33
-4%
|
34
+5%
|
32
-6%
|
23
-28%
|
23
+0%
|
22
-4%
|
21
-8%
|
27
+31%
|
27
-1%
|
26
-2%
|
28
+7%
|
29
+5%
|
31
+5%
|
31
+2%
|
31
-1%
|
29
-7%
|
30
+5%
|
31
+4%
|
34
+10%
|
33
-4%
|
31
-5%
|
32
+2%
|
30
-5%
|
33
+10%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(30)
|
(29)
|
(29)
|
(30)
|
(28)
|
(29)
|
(29)
|
(28)
|
(27)
|
(27)
|
(26)
|
(26)
|
(29)
|
(30)
|
(33)
|
(36)
|
(38)
|
(38)
|
(39)
|
(38)
|
(35)
|
(33)
|
(33)
|
(33)
|
(36)
|
(36)
|
(36)
|
(36)
|
(35)
|
(35)
|
(35)
|
(35)
|
(35)
|
(37)
|
(38)
|
(39)
|
(39)
|
(37)
|
(36)
|
(36)
|
(40)
|
|
Selling, General & Administrative |
(24)
|
(23)
|
(24)
|
(24)
|
(23)
|
(23)
|
(23)
|
(22)
|
(22)
|
(22)
|
(22)
|
(22)
|
(23)
|
(25)
|
(27)
|
(29)
|
(32)
|
(31)
|
(32)
|
(30)
|
(24)
|
(23)
|
(22)
|
(21)
|
(25)
|
(25)
|
(25)
|
(25)
|
(25)
|
(25)
|
(25)
|
(25)
|
(25)
|
(26)
|
(26)
|
(27)
|
(27)
|
(27)
|
(27)
|
(28)
|
(29)
|
|
Research & Development |
(6)
|
(5)
|
(4)
|
(4)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(5)
|
(5)
|
(6)
|
(8)
|
(7)
|
(7)
|
(8)
|
(7)
|
(7)
|
(7)
|
(6)
|
(6)
|
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(7)
|
(7)
|
(7)
|
(6)
|
(6)
|
(6)
|
(6)
|
|
Depreciation & Amortization |
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
(5)
|
(5)
|
(4)
|
(4)
|
(5)
|
|
Operating Income |
(4)
N/A
|
(5)
-24%
|
(2)
+50%
|
0
N/A
|
4
+2 273%
|
3
-11%
|
3
-17%
|
2
-28%
|
1
-41%
|
1
-46%
|
(0)
N/A
|
(0)
-78%
|
(1)
-347%
|
(2)
-12%
|
(3)
-98%
|
(4)
-31%
|
(4)
+1%
|
(6)
-44%
|
(5)
+14%
|
(6)
-19%
|
(11)
-85%
|
(10)
+10%
|
(11)
-5%
|
(12)
-13%
|
(9)
+22%
|
(10)
-6%
|
(10)
-2%
|
(8)
+20%
|
(6)
+23%
|
(5)
+26%
|
(4)
+8%
|
(5)
-8%
|
(6)
-37%
|
(7)
-7%
|
(7)
-3%
|
(5)
+30%
|
(6)
-17%
|
(6)
-4%
|
(4)
+31%
|
(6)
-39%
|
(6)
-10%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
0
|
0
|
0
|
0
|
(3)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
2
|
3
|
4
|
4
|
|
Pre-Tax Income |
(4)
N/A
|
(5)
-26%
|
(2)
+51%
|
0
N/A
|
4
+1 069%
|
3
-11%
|
3
-16%
|
2
-27%
|
1
-39%
|
1
-39%
|
(0)
N/A
|
(0)
-340%
|
(1)
-505%
|
(2)
-15%
|
(3)
-101%
|
(4)
-29%
|
(4)
+3%
|
(6)
-45%
|
(5)
+16%
|
(6)
-19%
|
(11)
-92%
|
(10)
+10%
|
(10)
-6%
|
(12)
-16%
|
(9)
+22%
|
(10)
-6%
|
(10)
-3%
|
(8)
+20%
|
(7)
+20%
|
(5)
+23%
|
(3)
+47%
|
(3)
-12%
|
(6)
-88%
|
(7)
-19%
|
(9)
-32%
|
(8)
+13%
|
(6)
+26%
|
(4)
+28%
|
(2)
+56%
|
(2)
-36%
|
(6)
-160%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
2
|
2
|
1
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
(1)
|
(4)
|
(4)
|
(4)
|
(4)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Income from Continuing Operations |
(2)
|
(3)
|
(1)
|
0
|
2
|
2
|
2
|
1
|
1
|
0
|
(0)
|
(0)
|
(1)
|
(2)
|
(7)
|
(8)
|
(8)
|
(9)
|
(5)
|
(6)
|
(11)
|
(10)
|
(10)
|
(12)
|
(9)
|
(10)
|
(10)
|
(8)
|
(7)
|
(5)
|
(3)
|
(3)
|
(6)
|
(7)
|
(9)
|
(8)
|
(6)
|
(4)
|
(2)
|
(2)
|
(6)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(2)
N/A
|
(3)
-27%
|
(1)
+51%
|
0
N/A
|
2
+831%
|
2
-10%
|
2
-14%
|
1
-33%
|
1
-42%
|
0
-40%
|
(0)
N/A
|
(0)
-100%
|
(1)
-2 250%
|
(2)
-109%
|
(7)
-261%
|
(8)
-12%
|
(8)
-1%
|
(9)
-14%
|
(5)
+49%
|
(6)
-19%
|
(7)
-26%
|
(5)
+33%
|
(4)
+4%
|
(5)
-7%
|
(4)
+26%
|
(5)
-28%
|
(5)
-8%
|
(3)
+30%
|
(3)
+2%
|
(2)
+37%
|
0
N/A
|
(1)
N/A
|
(4)
-554%
|
(5)
-44%
|
(8)
-51%
|
(7)
+8%
|
(6)
+20%
|
(4)
+28%
|
(2)
+55%
|
(2)
-36%
|
(6)
-159%
|
|
EPS (Diluted) |
-0.1
N/A
|
-0.13
-30%
|
-0.06
+54%
|
0.02
N/A
|
0.14
+600%
|
0.12
-14%
|
0.1
-17%
|
0.07
-30%
|
0.04
-43%
|
0.02
-50%
|
0
N/A
|
0
N/A
|
-0.06
N/A
|
-0.12
-100%
|
-0.44
-267%
|
-0.5
-14%
|
-0.51
-2%
|
-0.58
-14%
|
-0.31
+47%
|
-0.37
-19%
|
-0.44
-19%
|
-0.3
+32%
|
-0.28
+7%
|
-0.31
-11%
|
-0.22
+29%
|
-0.29
-32%
|
-0.32
-10%
|
-0.22
+31%
|
-0.22
N/A
|
-0.14
+36%
|
0
N/A
|
-0.03
N/A
|
-0.23
-667%
|
-0.34
-48%
|
-0.51
-50%
|
-0.48
+6%
|
-0.38
+21%
|
-0.28
+26%
|
-0.12
+57%
|
-0.17
-42%
|
-0.44
-159%
|